Early in vivo CAR-T human data emerge from biotech trials in Chinanews2025-05-05T10:00:52+00:00May 5th, 2025|Endpoints News|
Topas claims success in early test of ‘immune tolerance’ celiac therapynews2025-05-05T07:01:57+00:00May 5th, 2025|Endpoints News|
Vertex drops AAV gene therapy research, tRNA therapy partnershipnews2025-05-02T19:29:13+00:00May 2nd, 2025|Endpoints News|
FDA withdraws compliance deadlines for makers of bone allograftsnews2025-05-02T15:43:57+00:00May 2nd, 2025|Endpoints News|
Feng Zhang’s protein nanoparticle startup Aera Therapeutics turns to lipid nanoparticles to jumpstart its pipelinenews2025-05-02T15:32:11+00:00May 2nd, 2025|Endpoints News|
#AACR25: Roche’s first results for Werner drug that uses synthetic lethalitynews2025-05-02T14:57:54+00:00May 2nd, 2025|Endpoints News|
Investors unveil plans for $1.3B cancer hub in London suburbsnews2025-05-02T10:52:42+00:00May 2nd, 2025|Endpoints News|
Moderna’s vaccine revenue miss disappoints Wall Streetnews2025-05-01T18:09:47+00:00May 1st, 2025|Endpoints News|
CROs raise the alarm as clients delay R&D plans over funding, tariff worriesnews2025-05-01T15:02:18+00:00May 1st, 2025|Endpoints News|
Moderna Q1 earnings: Company expands effort to control spending in ‘uncertain environment’news2025-05-01T10:30:47+00:00May 1st, 2025|Endpoints News|
